Expression of Vascular Endothelial Growth Factor A and Its Type ۱ Receptor in Supratentorial Neoplasm

  • سال انتشار: 1400
  • محل انتشار: مجله گزارش های بیوشیمی و زیست شناسی مولکولی، دوره: 10، شماره: 3
  • کد COI اختصاصی: JR_RBMB-10-3_002
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 173
دانلود فایل این مقاله

نویسندگان

Hamid Rezaee

Neurosurgery Department, Mashhad University of Medical Sciences, Mashhad, Iran.

Shadi Abbasnia

Immunology Research Centre, Inflammation and inflammatory Diseases division, Mashhad University of Medical Sciences, Mashhad, Iran.

Anita Alenabi

Shariati Hospital, Department of Pathology, Mashhad University of Medical Sciences, Mashhad, Iran.

Rosita Vakili

Immunology Research Centre, Inflammation and inflammatory Diseases division, Mashhad University of Medical Sciences, Mashhad, Iran.

Nasrin Moheghi

Genetic Laboratory, Qaem Hosp. Mashhad University of Medical Sciences, Mashhad, Iran.

Jalil Tavakol Afshari

Immunology Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyed Abdolrahim Rezaee

Immunology Research Centre, Inflammation and inflammatory Diseases division, Mashhad University of Medical Sciences, Mashhad, Iran.

چکیده

Background: Vascular endothelial growth factor (VEGF) is one of the main angiogenesis regulators in solid cancers. The brain solid tumors are life threatening diseases in which angiogenesis is an important phase of development and progression. In the present study the gene expression of VEGF-A and VEGF receptor (VEGF-R۱) were evaluated in CNS brain tumors. Methods: The quantification of the VEGF-A and VEGF-R۱ expressions was carried out by real-time PCR on fresh biopsies of ۳۸ supratentorial brain tumors compared to ۳۰ non-tumoral tissues. Then the correlations were investigated with clinic-pathological and demographic factors of the patients. Results: PCR products sequencing confirmed the validity of the qRT-PCR. Although, VEGF-A and VEGF-R۱ expression showed increased trends with progression of cell proliferation in different stages of astrocytoma (p=۰.۰۰۶,p=۰.۰۷, respectively), in case of VEGF-R۱ did not met ۹۵% confidence interval in other brain tumors. An increasing trend in VEGF-A and a declining trend in VEGF-R۱ expression from stage-I to II were observed in meningioma.VEGF-A and VEGF-R۱ expressions had not significant correlation with age and gender. Although, peritumoral brain edema (PTBE) in astrocytoma was significantly associated with tumor stages (p=۰.۰۱), VEGF-A and VEGF-R۱ had not associations with PTBE in meningioma and metastasis. Conclusion: VEGF-A is a valuable factor for prognosis of PTBE and malignancy stage in astrocytoma, and useful for monitoring of the treatment approaches.

کلیدواژه ها

Angiogenesis, Brain edema, Brain neoplasm, Peritumoral brain, VEGF, VEGFR۱.

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.